This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Fuster V, Gibbons RJ (2001) ACC AHA/ESC: Guidelines for the management of patients with atrial fibrillation. Eur Heart J 22:1852–1923
Boriani G, Biffi M, Branzi A (1998) Pharmacological treatment of atrial fibrillation: a review of prevention of recurrences and control of ventricular response. Arch Gerontol Geriatr 27:127–139
Alessie MA (1998) Atrial electrophysiologic remodeling: another vicious circle. J Cardiovasc Elettrophysiol 9:1378–1393
Verhorst PMJ, Kamp O, Welling RC (2001) Transesophageal echocardiographic predictors for maintenance of sinus rhythm after electrical cardioversion of atrial fibrillation. Am J Cardiol 79:1235–1239
Mattioli AV, Vivoli D, Bastia E (1997) Doppler echocardiographic parameters predictive of recurrence of atrial fibrillation of different etiologic origins. J Ultrasound Med 16:695–698
Deedwania PC, Singh BN, Ellenbogen K et al (1998) Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation. Observation from the Veterans Affairs Congestive Heart Failure Survival Trial of Anti-arrhythmic Therapy (CHF-STAT). Circulation 98:2574–2579
Anderson JL, Gilbert EM, Alpbert PL et al (1989) Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating anti-arrhythmic therapy. A multicenter double-blind crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group. Circulation 80:1557–1570
Pietersen H, Hellemann H (1991) Usefulness of flecainide for prevention of paroxysmal atrial fibrillation and flutter. Danish-Norwegian Flecainide Multicenter Study Group. Am J Cardiol 67:713–717
Carelli G, Dorian P (1996) Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. Am J Cardiol 77:53A–59A
Van Wijklm, Den Heijr P (1989) Flecainide versus quinidine in the prevention of paroxysms of atrial fibrillation. J Cardiovasc Pharmacol 13:32–36
Van Gelder IC, Crijnshj (1989) Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter. Am J Cardiol 64:1317–1321
Lee Sh, Chen S, Chiang CE et al (1996) Comparison of oral propafenone and quinidine as an initial treatment option in patients with symptomatic paroxysmal atrial fibrillation: a double-blind, randomized trial. J Intern Med 239:253–260
Reinol SC, Cantillon CO (1993) Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation. Am J Cardiol 79:1198–1202
Alboni P, Botto GL (2005) Out of hospital treatment of recent onset atrial fibrillation with the “pill in the pocket” approach. N Engl J Med (in press)
Kochiadakis GE, Igoumenidis NE, Marketou ME et al (2000) Low dose amiodarone and sotalol in the treatment of recurrent symptomatic atrial fibrillation: comparative placebo controlled study. Heart 84:251–257
Roy D, Talajic M (2000) Amiodarone to prevent recurrence of atrial fibrillation. N Engl J Med 342:913–920
Vitolo E, Tronci M, La Rovere M (1981) Amiodarone versus quinidine in the prophylaxis of atrial fibrillation. Acta Cardiol 36: 431–434
Vorperian VR, Havighurst TC (1997) Adverse effects of low dose amiodarone: a meta-analysis. J Am Coll Cardiol 30:791–798
Sing S, Zoble RG (2000) Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) study. Circulation 102:2385–2390
Greenbaum RA, Campbell TJ (1998) Conversion of atrial fibrillation and maintenance of sinus rhythm by dofetilide: DE EMERALD (European and Australian Multicenter Evaluative Research on Atrial Fibrillation Dofetilide) study. Circulation 98:1663–1671
Kuhlkamp V, Schirdewan A, (2000) Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation. A randomized doubleblind placebo-controlled study. J Am Coll Cardiol 36:139–146
Lucio E, Flores A (2003) Effectiveness of metoprolol in prevention of atrial fibrillation and flutter in the postoperative period of coronary artery by-pass graft surgery. Arq Bras Cardiol 82:42–46
Toboul P, Brugada, Capucci A (2003) Dronedarone for prevention of atrial fibrillation: a dose-ranging study. Eur Heart J 24:1481–1487
Rossiem Lown B (1967) The use of quinidine in cardioversion. Am J Cardiol 19:234–238
Cappucci A, Villani GQ, Aschieri D (2000) Oral amiodarone increases the efficacy of direct current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation. Eur Heart J 21:66–73
Botto GL, Belotti G, Ciro A, on behalf of the VERAF study group (2002) Verapamil in prevention of early recurrence of atrial fibrillation: final results of the VERAF study. Eur Heart J 23:660
De Simone A, De Pasquale M, De Matteis C, on behalf of the VEPARAF study (2003) Verapamil class antiarrhythmic drugs reduce atrial fibrillation recurrences after an electrical cardioversion (VEPARAF Study). Eur Heart J 24: 1425–1429
Madrid AH, Bueno MG (2002) Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation. A prospective and randomized study. Circulation 106:16
Chiaranda G, Cavarra ML, Busacca G (2004) The role of candesartan in the maintenance of sinus rhythm in patient with atrial fibrillation lasting > 48 h, Italian Heart J, 5(Suppl 5):C108
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Italia
About this paper
Cite this paper
Chiaranda, G., Cavarra, M., Romeo, C., Chiaranda, M., Regolo, T. (2005). Pharmacological Prevention of Arrhythmic Recurrences. In: Gulizia, M.M. (eds) Emerging Pathologies in Cardiology. Springer, Milano . https://doi.org/10.1007/88-470-0341-5_12
Download citation
DOI: https://doi.org/10.1007/88-470-0341-5_12
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0311-8
Online ISBN: 978-88-470-0341-5
eBook Packages: MedicineMedicine (R0)